Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study

- Jafari M. , et al.

2. Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia

- Al-Jedai A. , et al.

3. The Lebanese health economic evaluation guideline

- Daccache C. , et al.

4. Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea

- Shih Y.R. , et al.

5. Study on the Medical Insurance Budget Impact Analysis Guideline in Some European Countries and Its Enlightenment to China

- Liu P. , et al.

6. A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions

- Foroutan N. , et al.

7. Administrative process and criteria ranking for drug entering health insurance list in Iran-TOPSIS-based consensus model

- Viyanchi A. , et al.

8. Budget impact analysis of using omeprazole immediate-release oral suspension in replace of intravenous pantoprazole in critically ILL patients

- Foroutan N. , et al.